GFP labelling and epigenetic enzyme expression of bone marrowderived mesenchymal stem cells from bovine foetuses
Author
dc.contributor.author
Díaz, P.
Author
dc.contributor.author
Cuevas, F.
Author
dc.contributor.author
Peralta, O. A.
Admission date
dc.date.accessioned
2015-08-21T18:48:32Z
Available date
dc.date.available
2015-08-21T18:48:32Z
Publication date
dc.date.issued
2015
Cita de ítem
dc.identifier.citation
Research in Veterinary Science 99 (2015) 120–128
en_US
Identifier
dc.identifier.other
DOI: 10.1016/j.rvsc.2014.12.019
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/133020
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Mesenchymal stem cells (MSC) are multipotent progenitor cells defined by their ability to self-renew
and give rise to differentiated progeny. Since MSC from adult tissues represent a promising source of cells
for a wide range of cellular therapies, there is high scientific interest in better understanding the potential
for genetic modification and the mechanism underlying differentiation. The main objective of this
study was to evaluate the potential for gene delivery using a GFP vector and lipofectamine, and to quantify
the expression of epigenetic enzymes during foetal bMSC multilineage differentiation. Proportion
of GFP-positive cells achieved (15.7% ± 3.5) indicated moderately low transfection efficiency. Analysis of
DNA methyltransferase expression during MSC multilineage differentiation suggested no association with
osteogenic and chondrogenic differentiation. However, up-regulation of KDM6B expression during osteogenic
differentiation was associated with adoption of osteogenic lineage. Furthermore, increase in
epigenetic enzyme expression suggested an intense epigenetic regulation during adipogenic differentiation.